Similarly, early studies demonstrated that interaction of PD-1 and its ligand PD-L1 on tumor cells represents a tumor immune escape mechanism and that blockade of the PD-1/PD-L1 axis reduced tumor growth in experimental models (29). The gene discussed is PDCD1; the disease is neoplasm.